Original and generic drugs

Original research drugs, as the name suggests, are original new drugs. The research and development investment of original drugs is high, the innovation difficulty is high, the market cycle is long, and the price is relatively high. The rapid development of domestically produced innovative drugs not only greatly improves the accessibility of medication for patients, but also significantly reduces their medication burden. Developing innovative drugs is related to the development of the pharmaceutical industry and the health and well-being of the people. Generic drugs refer to drugs that have the same active ingredients, dosage forms, administration routes, and therapeutic effects as the generic drug, and can be used as substitutes for the original drug. Its application helps to reduce medical costs, improve drug accessibility, and enhance the level of medical services, with significant economic and social benefits.

The unit is designed for unsupervised public use: controls are recessed or shielded, moving parts are enclosed, and the interface is operable by a child of about six with no instruction. Where a screen is used, the language can be switched without changing the hardware, and the content can be replaced on site.

The original drug has the characteristics of "high investment, high return, high risk, and long cycle". The research and development cycle can reach 15 to 20 years. The successful development of the original drug may still result in abandonment due to side effects, therapeutic effects, and other factors. The development of generic drugs is relatively much simpler. No need to go through a lot of trouble, just use the original drug as a reference, explore synthesis methods, conduct brief clinical trials, and after meeting relevant standards and regulations, it can be launched on the market. The total research and development time is generally 10-13 months.